Last 0.16 GBp
Change Today -0.005 / -3.12%
Volume 5.8M
PYC On Other Exchanges
As of 11:37 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

physiomics plc (PYC) Snapshot

0.16 GBp
Previous Close
0.16 GBp
Day High
0.16 GBp
Day Low
0.16 GBp
52 Week High
10/1/13 - 0.31 GBp
52 Week Low
09/5/13 - 0.11 GBp
Market Cap
Average Volume 10 Days
-0.0001 GBp
Shares Outstanding
Dividend Yield
Current Stock Chart for PHYSIOMICS PLC (PYC)

Related News

No related news articles were found.

physiomics plc (PYC) Related Businessweek News

No Related Businessweek News Found

physiomics plc (PYC) Details

Physiomics Plc provides outsourced systems and computational biology services to pharmaceutical companies in the United Kingdom and other European countries. The company’s services include Virtual Tumour, which is used to optimize the dosing and scheduling of oncology drugs in pre-clinical trials; and Virtual Tumour Preclinical that provides a rationale for designing a schedule, and allows to prioritize the drug combinations; and services to predict cardiac toxicity. It also offers model based drug development services, including population PKPD analysis of clinical data, back-translational analysis, optimal design of future studies, and preparation for due diligence. In addition, the company offers target validation and lead selection services. Further, it is developing Virtual Tumor Clinical to predict optimal regimens for human clinical trials; cardiac tox prediction service to predict unwanted toxic side effects of drug candidates early on in the drug discovery process; and drug combinations database for researchers and clinicians to access literature data on pre-clinical and clinical regimens and their effects. It has collaboration and partnership agreements with Eli Lilly, Sareum, Institute of Cancer Research, Cancer Research Technology, Cyclacel Pharmaceutical, ValiRx, Phramacometrics, Institute of Life Science at Swansea University, TEMPO, and Bayer Technology Services GmbH. The company is based in Oxford, the United Kingdom.

physiomics plc (PYC) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: 106.9K GBP
Chief Operating Officer, Director and Member ...
Total Annual Compensation: 59.5K GBP
Compensation as of Fiscal Year 2013.

physiomics plc (PYC) Key Developments

Physiomics plc Signs New Contract

Physiomics plc announced that it has signed a new contract with a global pharmaceutical company. The project will involve adapting the existing Virtual Tumour to model immunomodulatory agents, currently a significant focus of cancer research. The initial phase of the project will be focused on making pre-clinical predictions. If successful, the project may be extended to also adapt Virtual Tumour Clinical to immune therapies in cancer. The initial project will start immediately and will be completed by the end of 2014. The project will be performed on a fee-for-service basis.

Physiomics plc Signs Heads of Terms Agreement with Diatech Pharmacogenetics Srl

Physiomics plc announced that it has signed a Heads of Terms agreement with Diatech Pharmacogenetics srl (Diatech) to negotiate a Collaboration Agreement. Under the terms of the anticipated Collaboration Agreement Physiomics and Diatech will develop an innovative in-silico platform to personalize cancer patient treatment. This anticipated new in-silico platform will combine pharmacological information related to cancer drugs with genomic and physiological information about the patient, to predict which treatments and regimens are likely to lead to an increase in survival. The platform will initially be used to support physicians to make the best choice of available treatment options for patients. Ultimately, the software could be further developed to choose the right patient groups for clinical trials of new drugs. The parties anticipate signing a full collaboration agreement within 6 months and a further announcement will be made at that time if it is executed.

Physiomics plc Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-12-2014

Physiomics plc Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-12-2014 . Venue: London, United Kingdom.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PYC:LN 0.16 GBp -0.005

PYC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PYC.
View Industry Companies

Industry Analysis


Industry Average

Valuation PYC Industry Range
No financial data is available for PYC.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHYSIOMICS PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at